TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07903870: A Study of the Efficacy of the Postbiotic pA1c®HI as a Metabolic Regulator in Healthy Individuals With Hyperglycemia

Sponsor: Genbioma Aplicaciones SL · Phase: PHASE1 · Area: RARE_ORPHAN · Target Enrollment: 100 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$11,206,400

Rescue Site Savings

+$7,389,220

Unlock Full NCT07903870 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07903870 Rescue Dossier →